$GNBT GENEREX BIOTECHNOLOGY CORP Insider Trading
Get free email notifications about insider trading in GENEREX BIOTECHNOLOGY CORP.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in GENEREX BIOTECHNOLOGY CORP. Insider overview, share value development, latest insider transactions and email notifications about new events in GENEREX BIOTECHNOLOGY CORP for free.
CIK Number: 0001059784
IRS Number: 820490211
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Trading Symbol: GNBT
Company Address: 10102 USA TODAY WAY MIRAMAR 33025
Phone number: 416-364-2551
Market Capitalization: $10.45M
Prev close: $0.01
Average Daily Volume: 1,722,060
Days Low: $0.01
Year Low: $0.00
Year High: $0.02
GENEREX BIOTECHNOLOGY CORP Latest Insider Transactions
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Dec 14 2018 | GNBT | GENEREX BIOTECHNOL ... | Haines Harold Gray | Buy | P | 2.12 | 945 | 2,003 | 945 | 0 to 945 | |
Dec 14 2018 | GNBT | GENEREX BIOTECHNOL ... | Haines Harold Gray | Buy | P | 2.10 | 555 | 1,166 | 555 | 0 to 555 | |
Dec 14 2018 | GNBT | GENEREX BIOTECHNOL ... | Haines Harold Gray | Buy | P | 1.05 | 8,000 | 8,400 | 8,000 | 0 to 8 K | |
Dec 14 2018 | GNBT | GENEREX BIOTECHNOL ... | Haines Harold Gray | Buy | P | 1.03 | 300 | 309 | 300 | 0 to 300 | |
Oct 15 2018 | GNBT | GENEREX BIOTECHNOL ... | Ro Andrew | SVP & Chief Investm ... | Option Exercise | A | 2.23 | 4,500 | 10,035 | 4,500 | |
Oct 15 2018 | GNBT | GENEREX BIOTECHNOL ... | Purcell Richard David Jr. | SVP of Research & D ... | Option Exercise | A | 2.23 | 4,500 | 10,035 | 4,500 | |
Oct 15 2018 | GNBT | GENEREX BIOTECHNOL ... | MCGEE BRIAN | Director | Option Exercise | A | 2.23 | 1,000 | 2,230 | 1,000 | |
Oct 15 2018 | GNBT | GENEREX BIOTECHNOL ... | Lyman Gary Herbert | Director | Option Exercise | A | 2.23 | 1,000 | 2,230 | 1,000 | |
Oct 15 2018 | GNBT | GENEREX BIOTECHNOL ... | FLETCHER MARK | EVP General Counsel ... | Option Exercise | A | 2.23 | 4,500 | 10,035 | 4,500 | |
Oct 15 2018 | GNBT | GENEREX BIOTECHNOL ... | Corrao Mark | CFO & Treasurer | Option Exercise | A | 2.23 | 4,500 | 10,035 | 4,500 | |
Oct 15 2018 | GNBT | GENEREX BIOTECHNOL ... | Centofanti Kevin | Director | Option Exercise | A | 2.23 | 1,000 | 2,230 | 1,000 | |
Oct 15 2018 | GNBT | GENEREX BIOTECHNOL ... | Anderson James H Jr. | Director | Option Exercise | A | 2.23 | 1,000 | 2,230 | 1,000 | |
Feb 16 2016 | GNBT | GENEREX BIOTECHNOL ... | Brusegard David | Chief Operating Off ... | Option Exercise | M | 0.00 | 1,667,671 | 1,668 | 0 | |
Feb 16 2016 | GNBT | GENEREX BIOTECHNOL ... | Brusegard David | Chief Operating Off ... | Buy | M | 0.00 | 1,667,671 | 1,668 | 5,615,070 | 3.9 M to 5.6 M (+42.25 %) |
Feb 16 2016 | GNBT | GENEREX BIOTECHNOL ... | FLETCHER MARK | President & CEO | Option Exercise | M | 0.00 | 4,447,111 | 4,447 | 0 |